Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Cash from Operations (2022 - 2026)

Sagimet Biosciences' Cash from Operations history spans 5 years, with the latest figure at 8611000.0 for Q1 2026.

  • Quarterly Cash from Operations rose 40.76% to 8611000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 39725000.0 through Mar 2026, up 21.74% year-over-year, with the annual reading at 45650000.0 for FY2025, 7.58% down from the prior year.
  • Cash from Operations came in at 8611000.0 for Q1 2026, up from 11833000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3000.0 in Q2 2022 to a low of 19569000.0 in Q3 2024.
  • The 5-year median for Cash from Operations is 7287000.0 (2022), against an average of 8384500.0.
  • Year-over-year, Cash from Operations crashed 190566.67% in 2023 and then skyrocketed 47.98% in 2025.
  • Sagimet Biosciences' Cash from Operations stood at 7490000.0 in 2022, then rose by 5.43% to 7083000.0 in 2023, then crashed by 55.64% to 11024000.0 in 2024, then fell by 7.34% to 11833000.0 in 2025, then rose by 27.23% to 8611000.0 in 2026.
  • Per Business Quant, the three most recent readings for SGMT's Cash from Operations are 8611000.0 (Q1 2026), 11833000.0 (Q4 2025), and 10180000.0 (Q3 2025).